Nuveen Asset Management, LLC I Bio, Inc. Transaction History

Nuveen Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.23 - $0.46 $206,487 - $412,975	-897,772 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.3 - $0.61 $2,560 - $5,205	-8,534 Reduced 0.94%	897,772 $360,000
Q4 2021 Feb 14, 2022	SELL	$0.55 - $1.04 $39,465 - $74,626	-71,756 Reduced 7.34%	906,306 $580,000
Q3 2021 Nov 12, 2021	BUY	$1.06 - $1.52 $10,259 - $14,712	9,679 Added 1.0%	978,062 $1.2 Million
Q2 2021 Aug 16, 2021	BUY	$1.22 - $1.65 $436,713 - $590,637	357,962 Added 58.64%	968,383 $1.46 Million
Q1 2021 May 17, 2021	BUY	$1.18 - $2.62 $79,731 - $177,030	67,569 Added 12.45%	610,421 $940,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $2.24 $269,711 - $575,384	256,868 Added 89.82%	542,852 $570,000
Q3 2020 Nov 16, 2020	BUY	$1.7 - $6.41 $9,113 - $34,364	5,361 Added 1.91%	285,984 $581,000
Q2 2020 Aug 14, 2020	BUY	$0.87 - $2.46 $244,142 - $690,332	280,623 New	280,623 $623,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.